(Q36276594)

13 August 2017

1 reference

title

Interleukin-10 and the immune response against cancer: a counterpoint (English)

1 reference

13 August 2017

2

Francesco M Marincola

1 reference

13 August 2017

Simone Mocellin

1

1 reference

PubMed ID

16204623

13 August 2017

Howard A Young

series ordinal

3

1 reference

13 August 2017

4 October 2005

1 reference

Journal of Leukocyte Biology

13 August 2017

1 reference

13 August 2017

78

1 reference

13 August 2017

1043-1051

1 reference

13 August 2017

5

1 reference

Interleukin-10 in viral diseases and cancer: exiting the labyrinth?

13 August 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Tumor-host immune interactions and dendritic cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

T-cell subsets (Th1 versus Th2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Mechanisms of interleukin-10-mediated immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Regulatory activity of autocrine IL-10 on dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Danger signals: a time and space continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

IL-10 Induces Regulatory T Cell Apoptosis by Up-Regulation of the Membrane Form of TNF-

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

At the crossroads of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Natural killer cells and dendritic cells: rendezvous in abused tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

IL-10 stimulatory effects on human NK cells explored by gene profile analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Formyl-peptide receptors revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10-mediated Inhibition of free radical generation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Babesia bovis immunity. In vitro and in vivo evidence for IL-10 regulation of IFN-gamma and iNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

HLA-G and IL-10 expression in human cancer--different stories with the same message

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Altered immune responses in interleukin 10 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

A single amino acid determines the immunostimulatory activity of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Proinflammatory effects of IL-10 during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Principles of tumor immunosurveillance and implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin 10 increases CCR5 expression and HIV infection in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Inducing autoimmune disease to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0705358

21 January 2018

Identifiers

DOI

10.1189/JLB.0705358

1 reference

13 August 2017

1 reference

PubMed ID

16204623